MeSH Browser

MeSH Heading: 2019-nCoV Vaccine mRNA-1273
Tree Number(s): D12.776.828.868.228.500.500; D20.215.894.865.450.500.500; D20.215.894.899.085.250; D23.050.865.450.500.500
Unique ID: D000090983
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000090983
Scope Note: mRNA vaccine against SARS-CoV-2, developed by Moderna.
Entry Term(s): COVID-19 Vaccine Moderna; CX-024414; Elasomeran; M-1273; Moderna COVID-19 Vaccine; Moderna COVID-19 Vaccine RNA; Moderna COVID-19 Vaccine, Bivalent; Spikevax; TAK-919; mRNA-1273; mRNA-1273.211
Registry Numbers: EPK39PL4R4; 0
Public MeSH Note: 2022; 2019-NCOV VACCINE MRNA-1273 was indexed under COVID-19 VACCINES 2021
History Note: 2022(2021)
Date Established: 2022/01/01
Date of Entry: 2021/07/09
Revision Date: 2023/05/22

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M000747630
Registry Numbers: EPK39PL4R4
Scope Note: mRNA vaccine against SARS-CoV-2, developed by Moderna.
Terms: 2019-nCoV Vaccine mRNA-1273 Preferred Term
Term UI T001105738
Date04/30/2021
LexicalTag NON
ThesaurusID NLM (2022); COVID-19 Vaccine Moderna
Term UI T001105736
Date04/30/2021
LexicalTag NON
ThesaurusID NLM (2022); mRNA-1273
Term UI T001105737
Date04/30/2021
LexicalTag NON
ThesaurusID NLM (2022); Moderna COVID-19 Vaccine RNA
Term UI T001115260
Date12/02/2021
LexicalTag NON
ThesaurusID NLM (2022); Moderna COVID-19 Vaccine
Term UI T001115261
Date12/02/2021
LexicalTag NON
ThesaurusID NLM (2022)

2019-nCoV Vaccine mRNA-1273 MeSH Descriptor Data 2025